GILENYA

Identification of Gilenya

No description

Google image searchProduct monograph

Active ingredient

fingolimod (fingolimod hydrochloride), 0.25 MG

DIN: 02482533

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 03-JAN-2019

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AE — Sphingosine-1-phosphate (S1P) receptor modulators (ATC, ATC/DDD)
• L04AE01 — FINGOLIMOD (ATC/DDD)

Reference brand drug: Gilenya

External Links for Gilenya

Search on Google

• Gilenya side effects
• Gilenya dosage
• fingolimod side effects
• fingolimod dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find gilenya photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.